Castik Capital sells Acrotec Group to Carlyle Group

Photo: Jona­than Zafrani, Mana­ging Direc­tor in Carlyle’s Euro­pean Buyout Team
8. Decem­ber 2020

London / Deli­vier — Global invest­ment firm The Carlyle Group (NASDAQ: CG) today has agreed to acquire the Acro­tec Group, in part­ners­hip with its manage­ment team, from Castik Capi­tal (photo: Michael Phil­ipps, foun­der of Casik Capi­tal). The tran­sac­tion is subject to regu­la­tory appro­vals and is expec­ted to close in Q1 2021.

Head­quar­te­red in Deve­lier, Switz­er­land, Acro­tec is a leading inde­pen­dent supplier of high precision indus­trial appli­ca­ti­ons to the watch­ma­king and MedTech indus­tries as well as other high value indus­trial end markets, such as Auto­mo­tive, Elec­tro­nics and Aero­space. The company is a market-leading supplier into the estab­lis­hed Swiss luxury watch-making market, manu­fac­tu­ring criti­cal compon­ents for mecha­ni­cal watch move­ments with major luxury watch brands as key custo­mers. Acro­tec recently expan­ded its posi­tion as a trus­ted MedTech contract manu­fac­tu­rer lever­aging its high-precision engi­nee­ring capa­bi­li­ties to service a diver­si­fied base of global custo­mers. The company employs appro­xi­mately 1,200 people across 18 loca­ti­ons and exports to over 40 countries.

Expan­sion plans for Acrotec’s MedTech business 

The Carlyle Group will support Acro­tec in acce­le­ra­ting its growth plan through the deve­lo­p­ment of its exis­ting plat­form and through acqui­si­ti­ons. Lever­aging Carlyle’s global Health­care exper­tise and network, the part­ners­hip will seek to broa­den Acrotec’s MedTech busi­ness with expan­sion into new services and geogra­phies in Europe and in the United States.

Fran­çois Billig, foun­der and CEO of the Acro­tec Group, said: “In Carlyle, I am deligh­ted that we have found a part­ner that under­stands and appre­cia­tes the core values of the Group. This part­ners­hip, which repres­ents an important mile­stone in Acrotec’s history, will signi­fi­cantly acce­le­rate our growth and diver­si­fi­ca­tion plan while remai­ning loyal to our core busi­ness in high precision appli­ca­ti­ons. Castik has been a valu­able part­ner over the past four years, suppor­ting the busi­ness to conso­li­date its leading posi­tion in mecha­ni­cal watch making, and over­see­ing a key phase of its deve­lo­p­ment, while respec­ting the values of the Group.”

Jona­than Zafrani (photo), Mana­ging Direc­tor of the Carlyle Europe Part­ners advi­sory team, said: “We were attrac­ted to Acro­tec given its strong entre­pre­neu­rial spirit, its market-leading posi­ti­ons in the growing Swiss mecha­ni­cal watch market as well as for various precision high-tech appli­ca­ti­ons, and the attrac­tive growth oppor­tu­nity in the global MedTech contract manu­fac­tu­ring market. The company has a strong repu­ta­tion with its custo­mers for manu­fac­tu­ring compon­ents that require the highest level of tech­no­logy and craft­s­manship. We are exci­ted to part­ner with the Acro­tec manage­ment team and look forward to lever­aging our signi­fi­cant exper­tise in Indus­tri­als and Health­care to support Acrotec’s future growth.”

Michael Phil­lips, Invest­ment Part­ner and member of the Board of Mana­gers of Castik Capi­tal S.à r.l., said: “It was a great plea­sure suppor­ting Fran­çois and his entre­pre­neu­rial manage­ment team at Acro­tec over the last four years. During Castik’s owners­hip, the company pursued an active conso­li­da­tion stra­tegy, acqui­ring 12 stra­te­gic add-ons and success­fully expan­ding into the MedTech indus­try. We wish Acro­tec all the best in the future and are confi­dent that Carlyle is the right part­ner to further drive the company’s excep­tio­nal performance.”

About Acrotec

Acro­tec is an inde­pen­dent group crea­ted by micro­me­cha­nics profes­sio­nals. Its main objec­tive is to be a refe­rence subcon­trac­tor by offe­ring a wide range of manu­fac­tu­ring proces­ses for precision compon­ents. Its stra­tegy is both to provide “Swiss Made” quality products to the entire watch indus­try as well as to the auto­mo­tive, elec­tro­nics, medi­cal, jewelry and aero­nau­tics indus­tries. Acro­tec distin­guis­hes itself by the extent of the know-how exer­cised under the same roof, in precision machi­ning (CNC turning, CNC multispindle turning, cam-opera­­ted turning, 3 & 5 axis milling, micro-turning, trans­fer and machi­ning of precious metals), by support proces­ses (surface treat­ment, cutting, assem­bly, heat treat­ment, deco­ra­tion and laser engra­ving) and by speci­fic proces­ses (realiz­a­tion of compon­ents by UV-Liga, wire erosion/sinking, machi­ning of synthe­tic stones, lami­na­tion, shaping of springs, realiz­a­tion of machi­nes and tools and engra­ving on sili­con — DRIE). Curr­ently, the Group has more than 1,200 employees.

About The Carlyle Group

The Carlyle Group (NASDAQ: CG) is a global invest­ment firm with deep indus­try exper­tise that deploys private capi­tal across four busi­ness segments: Corpo­rate Private Equity, Real Assets, Global Credit and Invest­ment Solu­ti­ons. With $230 billion of assets under manage­ment as of Septem­ber 30, 2020, Carlyle’s purpose is to invest wisely and create value on behalf of its inves­tors, port­fo­lio compa­nies and the commu­nities in which we live and invest. The Carlyle Group employs more than 1,800 people in 30 offices across six conti­nents. Further infor­ma­tion is avail­able at Follow The Carlyle Group on Twit­ter @OneCarlyle

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at]